GLP-1 medications are expensive but produce substantially greater weight loss with documented health benefits beyond the scale
The role of GLP-1 agonists on a persons appetite and caloric intake has become better understood over the years
In India, 90% of type 2 diabetes cases are attributable in part to excess weight or obesity
Sitagliptin was approved in 2006, but in contrast to the GLP-1 agonists, DPP4 inhibitors have little or no effect on body weight
Prez MM, Gonalves ECS, Vici AC, Salgado JCS, de Moraes PMDLT (2019) In: Yadav AN, Mishra S, Singh S, Gupta A (eds) Fungal lipases: versatile tools for white biotechnology, in recent advancement in white biotechnology through fungi: volume 1: diversity and enzymes perspectives, pp 361404
At Sage Wellness, we believe in goal-directed, individualized treatment